The markets opened lower with the Dow losing 33 points to 18,235 as the nation's unemployment rate ticked up to 5.0%. Nasdaq slipped 4 points to 5,302.
On the upside
HC Wainwright initiated coverage of Lipocine (Nasdaq: LPCN) with a Buy rating and a $25 price target.
Gap (NYSE: GPS) reported a smaller than expected drop in September same store sales.
Bargain hunters lifted shares of McEwen Minig (NYSE: MUX).
On the downside
Clovis Oncology (Nasdaq: CLVS) reported efficacy and safety data from its New Drug Application for rucaparib.
Novavax (Nasdaq: NVAX) rescheduled its 4th annual Investor and Analyst Meeting.
Honeywell (NYSE: HON) cut its third quarter forecast.
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 lost 4 points to 2,156. Bitcoin rose 4 points to $614.
